Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 1, 2015, Pages 115-122

  van Mens, S P ^a,b   van Deursen, A M M ^c,d   de Greeff, S C ^e   de Melker, H E ^e   Schouls, L M ^e   van der Ende, A ^f   Bonten, M J M ^b   Sanders, E A M ^d   Vlaminckx, B J M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Linnaeus Institute   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ADOLESCENT; ADULT; AGED; BACTEREMIA; COMMUNITY ACQUIRED INFECTION; COMPARATIVE STUDY; COMPLICATION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIA; SURVIVAL; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84927910009     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2209-5     Document Type: Article

References (30)

1. Miniño AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59(10):1–126
2. World Health Organization (WHO) (2004) The global burden of disease: 2004 update. WHO, Geneva, Switzerland. Available online at: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
3. van der Poll T, Opal SM (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374(9700):1543–1556
4. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J (2010) Etiology of community-acquired pneumonia: Increased microbiological yield with new diagnostic methods. Clin Infect Dis 50(2):202–209
5. Blasi F, Mantero M, Santus P, Tarsia P (2012) Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect 18(Suppl 5):7–14
6. Burgos J, Falcó V, Borrego A et al (2013) Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect 19(4):385–391
7. Kang CI, Song JH, Kim SH et al (2013) Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia. J Infect 66(1):34–40
8. Musher DM, Alexandraki I, Graviss EA et al (2000) Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 79(4):210–221
9. Vernet G, Saha S, Satzke C et al (2011) Laboratory-based diagnosis of pneumococcal pneumonia: state of the art and unmet needs. Clin Microbiol Infect 17(Suppl 3):1–13
10. Smith MD, Derrington P, Evans R et al (2003) Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol 41(7):2810–2813
11. Sinclair A, Xie X, Teltscher M, Dendukuri N (2013) Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol 51(7):2303–2310
12. Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72
13. Lim WS, Baudouin SV, George RC et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1–iii55
14. Wiersinga WJ, Bonten MJ, Boersma WG et al (2012) SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med 70(2):90–101
15. van Deursen AM, van Mens SP, Sanders EA et al (2012) Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis 18(11):1729–1737. doi:10.3201/eid1811.120329
16. Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382
17. Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243–250
18. Lin SH, Lai CC, Tan CK, Liao WH, Hsueh PR (2011) Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect 139(9):1307–1316
19. Coburn B, Morris AM, Tomlinson G, Detsky AS (2012) Does this adult patient with suspected bacteremia require blood cultures? JAMA 308(5):502–511
20. Naucler P, Darenberg J, Morfeldt E, Ortqvist A, Henriques Normark B (2013) Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Thorax 68(6):571–579
21. Kalin M, Ortqvist A, Almela M et al (2000) Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182(3):840–847
22. Skovgaard M, Schønheyder HC, Benfield T et al (2013) Impact of positive chest X-ray findings and blood cultures on adverse outcomes following hospitalized pneumococcal lower respiratory tract infection: a population-based cohort study. BMC Infect Dis 13:197. doi:10.1186/1471-2334-13-197
23. File TM (2003) Community-acquired pneumonia. Lancet 362(9400):1991–2001
24. Alanee SR, McGee L, Jackson D et al (2007) Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 45(1):46–51
25. Klemets P, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP (2008) Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies. BMC Infect Dis 8:96. doi:10.1186/1471-2334-8-96
26. Jover F, Cuadrado JM, Andreu L et al (2008) A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med 19(1):15–21
27. Huijts SM, Pride MW, Vos JM et al (2013) Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia. Eur Respir J 42(5):1283–1290
28. Leeming JP, Cartwright K, Morris R, Martin SA, Smith MD; South-West Pneumococcus Study Group (2005) Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. J Clin Microbiol 43(10):4972–4976
29. Sheppard CL, Harrison TG, Smith MD, George RC (2011) Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples. J Med Microbiol 60(Pt 1):49–55
30. Sherwin RL, Gray S, Alexander R et al (2013) Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. J Infect Dis 208:1813–1820